发明名称 USE OF PURIFIED BONE MORPHOGENIC PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR USE IN A METHOD FOR IMPROVING INTEGRATION OF AN OSTEOCHONDRAL AUTOGRAFT OBTAINED BY MOSAICOPLASTY
摘要 Methods and compositions are provided for the treatment of articular cartilage defects and disease involving the combination of the tissue, such as osteochondral grafts, with active growth factor. The active growth factor is preferably a composition containing at least one bone morphogenetic protein and a suitable carrier. The method results in the regeneration of functional repair of articular cartilage tissues.
申请公布号 IL144523(A) 申请公布日期 2012.10.31
申请号 IL20010144523 申请日期 2001.07.24
申请人 GENETICS INSTITUTE, LLC 发明人
分类号 A61K38/00;A61K35/32;A61K38/18;A61K38/22;A61L27/22;A61L27/38;A61P19/04;C07K14/51 主分类号 A61K38/00
代理机构 代理人
主权项
地址